Paul Silber is a Founding Principal at Blu Venture Investors. He launched and led In Vitro Technologies, Inc. as President & CEO for more than a decade. In 2006, he led the successful sale of the company. He has a track record of growing a successful biotech company from inception to sale, focusing on innovation, execution, and creation of a valuable brand. Paul has a Ph.D. in Toxicology and holds several patents. Currently, Paul is on the Board of Directors or acts as an Advisor to Evergreen Advisors LLC, PathSensors Inc., LKC, and The Biotechnical Institute of Maryland. In addition, he is an active Investor in many mid-Atlantic companies.